61 results on '"Hasle, Henrik"'
Search Results
2. Treatment of Molecular Relapse by Cessation of Immunosuppression After Hematopoietic Stem Cell Transplantation in Pediatric FLT3-ITD AML Monitored by WT1 Expression in Peripheral Blood
3. Liver diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): A population‐based cohort study of 32,839 one‐year survivors
4. Cancer Screening in Li-Fraumeni Syndrome
5. Strategies for reducing the treatment‐related physical burden of childhood acute myeloid leukaemia – a review
6. Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group
7. Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries
8. The Adult Life After Childhood Cancer in Scandinavia (ALiCCS) Study: Design and Characteristics
9. Cardiovascular disease in Adult Life after Childhood Cancer in Scandinavia: A population-based cohort study of 32,308 one-year survivors
10. Arthritis as presenting manifestation of acute lymphoblastic leukaemia in children
11. Extreme Doses of Intravenous Methadone for Severe Pain in Two Children With Cancer
12. The applicability of the WHO classification in paediatric AML. A NOPHO-AML study
13. Renal, Gastrointestinal, and Hepatic Late Effects in Survivors of Childhood Acute Myeloid Leukemia Treated with Chemotherapy Only—A NOPHO-AML Study
14. Challenges for Children and Adolescents With Cancer in Europe: The SIOP-Europe Agenda
15. A critical review of which children with acute myeloid leukaemia need stem cell procedures
16. Mitochondrial 12S Ribosomal RNA A1555G Mutation Associated with Cardiomyopathy and Hearing Loss following High-Dose Chemotherapy and Repeated Aminoglycoside Exposure
17. Social conditions for people with Down syndrome: A register-based cohort study in Denmark
18. Pubertal Development and Fertility in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study
19. A novel RT-qPCR assay for quantification of the MLL-MLLT3 fusion transcript in acute myeloid leukaemia
20. Absolute immature platelet count may predict imminent platelet recovery in thrombocytopenic children following chemotherapy
21. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine
22. Hospitalizations among people with Down syndrome: A nationwide population-based study in Denmark
23. Outcome of poor response paediatric AML using early SCT
24. Efficacy of anti-IL-1 treatment in Majeed syndrome
25. High frequency of copy number alterations in myeloid leukaemia of Down syndrome
26. Genetic and epigenetic similarities and differences between childhood and adult AML
27. Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: A NOPHO-AML study
28. Advances in the prognostication and management of advanced MDS in children
29. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes
30. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia
31. Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia
32. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984–2003
33. Clinical Presentation of Griscelli Syndrome Type 2 and Spectrum of RAB27A mutations
34. Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study
35. Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children1
36. Splenectomy in Two Children With Autoimmune Lymphoproliferative Syndrome and Massive Splenomegaly
37. FREQUENCY AND SPECTRUM OF RAB27A GENE MUTATIONS IN PATIENTS WITH HEMOPHAGOCYTIC SYNDROMES
38. Treatment of the X-linked lymphoproliferative, Griscelli and Chédiak–Higashi syndromes by HLH directed therapy
39. The t(X;7)(q22;q34) in paediatric T-cell acute lymphoblastic leukaemia results in overexpression of the insulin receptor substrate 4 gene through illegitimate recombination with the T-cell receptor beta locus
40. Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals
41. A Novel Splice Mutation in the TP53 Gene Associated With Leydig Cell Tumor and Primitive Neuroectodermal Tumor
42. Non-Hematopoietic Stem Cell Transplantation Treatment of Juvenile Myelomonocytic Leukemia: A Retrospective Analysis And Definition of Response Criteria
43. Improved outcome after relapse in children with acute myeloid leukaemia
44. A Review of Anti-D Treatment of Childhood Idiopathic Thrombocytopenic Purpura
45. Risk of cancer in children with the diagnosis immaturity at birth
46. Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature
47. Few but severe viral infections in children with cancer: A prospective RT-PCR and PCR-based 12-month study
48. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992–2001
49. Acute leukaemia in children with Down syndrome: a population-based Nordic study
50. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients – results from a single-centre study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.